Dr Roberto Alonzi

Dr Roberto Alonzi

Clinical oncology 04431448

  • Bupa Platinum consultant
  • Fee assured
  • Open Referral network
Bupa Platinum consultant
Fee assured
Open Referral network

Specialises in

  • Gynaecology
  • Urology


  • Face-to-face consultations
  • Video and telephone consultations
  • Home chemotherapy

About me

Dr Roberto Alonzi has a special interest in urological and gynaecological malignancies and is a consultant clinical oncologist at Mount Vernon Cancer Centre. Dr Alonzi trained at Guy’s and St Thomas’ hospitals in London and achieved a 1st Class honours BSc degree followed by MBBS in 1997. Following his general training and membership of the Royal College of Physicians, his specialist training took place in London at Hammersmith hospital, Charing Cross hospital and Mount Vernon Cancer Centre resulting in a Fellowship of the Royal College of Radiologists in 2004. Dr Alonzi studied for his research degree at the Gray Cancer Institute and University College London and was awarded an MD in 2008.

Dr Alonzi has a long experience in the treatment of prostate cancer, bladder cancer, gynaecological cancers and carcinoma of unknown primary. He has one of the largest brachytherapy practices in the UK and is a leading radiotherapist using all radiotherapy technologies including cyberknife, intensity modulated radiotherapy and image guidance. He also treats patients with systemic therapies such as chemotherapy, immunotherapy, hormonal therapy and targeted biological treatments, including new agents within the context of clinical trials.

Dr Alonzi’s has a major academic interest in the treatment of prostate cancer. These research interests include the development of biologically targeted image-guided precision radiotherapy using brachytherapy, salvage high dose rate brachytherapy for radio-recurrent prostate cancer, tumour oxygenation with the development of magnetic resonance based hypoxia imaging for targeted radiotherapy planning, the radiobiology of ultra-hypofractionation, focal and focussed therapy for prostate Cancer using high dose rate brachytherapy and stereotactic body radiotherapy and the use of radiation sensitizers in prostate cancer.

Areas of interest

Prostate cancer; Bladder cancer; Urological oncology; Brachytherapy; Radiotherapy; Chemotherapy; Immunotherapy; Gynaecological oncology; Cervix cancer; Uterine Cancer; Carcinoma of Unknown Primary

Medical secretaries

About me
My qualifications & training
My private practice
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • X0003

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (5-50)

    Mount Vernon Cancer Centre (5-50) Chiltern Hospital (The) (5-50)

  • X0004

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)

    Mount Vernon Cancer Centre (5-50)

  • X0008

    Clinical supervision of external beam radiotherapy, for 16 or up to and including 30 fractions - (5-50)

    GenesisCare, Elstree (1-5) Mount Vernon Cancer Centre (1-5)

  • X6772

    Preparation for complex radiotherapy with Intensity Modulated Radiotherapy (IMRT) - (5-50)

    GenesisCare, Elstree (1-5) Mount Vernon Cancer Centre (1-5)

  • 20365

    Follow-up out-patient consultation - remote - (1-5)

  • X6544

    Delivery of a fraction of Intensity Modulated Radiotherapy (IMRT) including Image Guided Radiotherapy (IGRT) on a megavoltage machine - (1-5)

    GenesisCare, Elstree (1-5)

  • X6910

    Clinical supervision of the planning of a course of simple radiotherapy - (1-5)

    Mount Vernon Cancer Centre (1-5)

  • H4685

    Insertion of biodegradable perirectal spacer under image guidance - (1-5)

    Mount Vernon Cancer Centre (1-5)

  • Show All (12 )...
Report this page Edit details Print page

The information contained on Finder is submitted by consultants, therapists and healthcare services, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use.